California Public Employees Retirement System’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
Other funds holding RETA
CI
EC
CCM
BC
California Public Employees Retirement System's RETA Position: Q1 2022 in Review
California Public Employees Retirement System sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q1 2022, closing a stake of 54,226 shares — an estimated $1.43M sold.
California Public Employees Retirement System first reported a position in RETA in Q3 2018 and held it in 14 quarters. The position peaked at $14.4M in Q4 2019. 149 funds tracked by Wall St. Rank hold RETA as of Q1 2022.
- California Public Employees Retirement System reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q1 2022 after selling out during the quarter.
- California Public Employees Retirement System sold 54,226 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q1 2022, an estimated $1.43M.
- California Public Employees Retirement System first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2018 and held it in 14 quarters.
- California Public Employees Retirement System's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $14.4M in Q4 2019.
- 149 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q1 2022.
Based on California Public Employees Retirement System's 13F filing for Q1 2022, filed 4 May 2022.